Travere Therapeutics Inc (TVTX)
18.25
-0.01
(-0.05%)
USD |
NASDAQ |
Nov 22, 16:00
18.27
+0.02
(+0.11%)
Pre-Market: 20:00
Travere Therapeutics Enterprise Value: 1.526B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.526B |
| November 21, 2024 | 1.526B |
| November 20, 2024 | 1.495B |
| November 19, 2024 | 1.458B |
| November 18, 2024 | 1.458B |
| November 15, 2024 | 1.484B |
| November 14, 2024 | 1.543B |
| November 13, 2024 | 1.550B |
| November 12, 2024 | 1.565B |
| November 11, 2024 | 1.586B |
| November 08, 2024 | 1.650B |
| November 07, 2024 | 1.479B |
| November 06, 2024 | 1.451B |
| November 05, 2024 | 1.487B |
| November 04, 2024 | 1.514B |
| November 01, 2024 | 1.472B |
| October 31, 2024 | 1.467B |
| October 30, 2024 | 1.487B |
| October 29, 2024 | 1.535B |
| October 28, 2024 | 1.497B |
| October 25, 2024 | 1.467B |
| October 24, 2024 | 1.510B |
| October 23, 2024 | 1.500B |
| October 22, 2024 | 1.501B |
| October 21, 2024 | 1.511B |
| Date | Value |
|---|---|
| October 18, 2024 | 1.493B |
| October 17, 2024 | 1.523B |
| October 16, 2024 | 1.507B |
| October 15, 2024 | 1.479B |
| October 14, 2024 | 1.460B |
| October 11, 2024 | 1.380B |
| October 10, 2024 | 1.434B |
| October 09, 2024 | 1.472B |
| October 08, 2024 | 1.286B |
| October 07, 2024 | 1.290B |
| October 04, 2024 | 1.288B |
| October 03, 2024 | 1.165B |
| October 02, 2024 | 1.182B |
| October 01, 2024 | 1.191B |
| September 30, 2024 | 1.191B |
| September 27, 2024 | 1.124B |
| September 26, 2024 | 1.203B |
| September 25, 2024 | 1.165B |
| September 24, 2024 | 1.166B |
| September 23, 2024 | 1.163B |
| September 20, 2024 | 1.216B |
| September 19, 2024 | 1.205B |
| September 18, 2024 | 1.150B |
| September 17, 2024 | 1.154B |
| September 16, 2024 | 1.144B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
150.98M
Minimum
Nov 09 2023
1.710B
Maximum
Feb 26 2021
958.69M
Average
1.031B
Median
May 25 2023
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -31.63M |
| Electromed Inc | 238.10M |
| Xtant Medical Holdings Inc | 83.10M |
| Myomo Inc | 147.33M |
| Catheter Precision Inc | 3.859M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -54.81M |
| Revenue (Quarterly) | 62.90M |
| Total Expenses (Quarterly) | 118.92M |
| EPS Diluted (Quarterly) | -0.70 |
| Gross Profit Margin (Quarterly) | 97.41% |
| Profit Margin (Quarterly) | -87.14% |
| Earnings Yield | -24.93% |
| Normalized Earnings Yield | -24.05 |